Tenax Announces Publication Titled “Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial ”
Apr 9, 2021
Tenax Therapeutics Announces Continuation of Board Refreshment Program as Three Long-Serving Directors Volunteer to Not Stand for Re-Election at the Upcoming 2021 Annual Meeting of Stockholders
Apr 7, 2021
Tenax Therapeutics Reports Fiscal Year 2020 Results and Provides Business Update
Mar 31, 2021
Tenax Therapeutics to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
Mar 4, 2021
Tenax Therapeutics, Inc. Expands Board of Directors
Mar 2, 2021
Tenax Therapeutics Schedules Conference Call to Discuss Its Transformative Acquisition of PH Precision Med
Jan 20, 2021
Tenax Therapeutics, Inc. Announces Transformative Acquisition of PH Precision Med
Jan 19, 2021